13F

Stock

CNS Pharmaceuticals, Inc.

CNSP · held by 12 managers

Reported value

$348.7K

Holders

12

+4 new · −2 exited

Holders’ est. mark

−$310.8K

Price effect on 8 books still in the name

Largest holder

$145.8K

Stonepine Capital Management, LLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
Stonepine Capital Management, LLC61K$145.8K−$139.6KCut−$110.6K
Ikarian Capital, LLC45.8K$110K−$130.6KCut−$130.6K
GEODE CAPITAL MANAGEMENT, LLC23.2K$55.7KNew
BOOTHBAY FUND MANAGEMENT, LLC13.5K$32.3K−$38.7KCut−$38.7K
Tower Research Capital LLC (TRC)1.31K$3.13KNew
UBS Group AG729$1.74K−$1.75KCut−$1.47K
Sound Income Strategies, LLC16$36−$77Cut−$77
BARRETT & COMPANY, INC.8$19−$23Cut−$23
MAI Capital Management3$8−$8Cut−$8
Caitong International Asset Management Co., Ltd1$2New
CITIGROUP INC1$2New
DANSKE BANK A/S1$2−$3Cut−$3

Who left

Positions as of Q1 2026. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.